Search for Clinical Trial Results

All - 63803 Studies Found

Status Study
Recruiting Study Name: SOM230 Ectopic ACTH-producing Tumors
Condition: Ectopic ACTH Syndrome
Date: 2016-04-26
Interventions: Drug: Pasireotide
Other Name: SOM230
Terminated Study Name: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Condition:
  • Pancreatic Neoplasm
  • Pituitary Neoplasm
  • Nelson Syndrome Date: 2009-07-22
    Interventions: Drug: pasireotide LAR
    Investigational drug pasireotide LAR was supplied in vials with 20 mg or 40 mg pow
Recruiting Study Name: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Condition:
  • Cushing's Syndrome
  • Ectopic Corticotropin Syndrome
  • Date: 2015-06-08
    Interventions: Drug: Osilodrostat
    Osilodrostat will be prescribed by the investigator. Osirodrostat 1 mg, 5 mg, 10 mg,
Recruiting Study Name: Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Date: 2013-12-21
Interventions:
  • Drug: F-DOPA PET Scan
  • Drug: Mifepristone
Terminated Study Name: Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
Date: 2007-01-12
Interventions: Drug: Mifepristone
Singe dose
Completed Study Name: Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Condition:
  • Cushing's Disease
  • Cushing's Syndrome

Date: 2011-06-07
Interventions: Drug: Mifepristone
mifepristone at doses from 300mg/day up to 1200mg/day
Completed Study Name: An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Date: 2009-07-09
Interventions: Drug: mifepristone
Mifepristone 300 mg to 1200 mg once daily
Other Name: Provide access to standard test procedures.
Completed Study Name: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Date: 2007-12-05
Interventions: Drug: mifepristone
Patients take mifepristone by mouth once a day. The dose is increased during schedule
Recruiting Study Name: Treatment of Cushing's Disease With R-roscovitine
Condition: Cushings Disease
Date: 2014-05-21
Interventions: Drug: R-roscovitine
See Arm Description
Other Names:
Next >>>